

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 9.23023893 |
| 2 | protein activation cascade (GO:0072376) | 8.23320629 |
| 3 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 8.20740133 |
| 4 | Fc-gamma receptor signaling pathway (GO:0038094) | 8.20740133 |
| 5 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 8.20740133 |
| 6 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 8.09294566 |
| 7 | glomerular filtration (GO:0003094) | 7.50382857 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 7.45306442 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 7.37315844 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.18318308 |
| 11 | retina homeostasis (GO:0001895) | 6.92919935 |
| 12 | cytidine metabolic process (GO:0046087) | 6.91503076 |
| 13 | cytidine catabolic process (GO:0006216) | 6.91503076 |
| 14 | cytidine deamination (GO:0009972) | 6.91503076 |
| 15 | humoral immune response (GO:0006959) | 6.87811234 |
| 16 | renal filtration (GO:0097205) | 6.70777352 |
| 17 | regulation of respiratory burst (GO:0060263) | 5.98182293 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 5.97043906 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.77931008 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.77931008 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.76057769 |
| 22 | cellular response to zinc ion (GO:0071294) | 5.70189183 |
| 23 | regulation of B cell differentiation (GO:0045577) | 5.62035716 |
| 24 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.57633315 |
| 25 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.57633315 |
| 26 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.49698373 |
| 27 | regulation of B cell proliferation (GO:0030888) | 5.49370844 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.35331420 |
| 29 | negative regulation of glucose import (GO:0046325) | 5.11343013 |
| 30 | regulation of cellular extravasation (GO:0002691) | 4.95442175 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.60232178 |
| 32 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.56040156 |
| 33 | B cell proliferation (GO:0042100) | 4.41312316 |
| 34 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.35571205 |
| 35 | negative regulation of glucose transport (GO:0010829) | 4.27369402 |
| 36 | mature B cell differentiation (GO:0002335) | 4.26698259 |
| 37 | negative regulation of B cell activation (GO:0050869) | 3.96955478 |
| 38 | regulation of B cell apoptotic process (GO:0002902) | 3.95250634 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.92015266 |
| 40 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.88730358 |
| 41 | regulation of B cell activation (GO:0050864) | 3.81279377 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.76627187 |
| 43 | positive regulation of Rap GTPase activity (GO:0032854) | 3.71466470 |
| 44 | positive regulation of immunoglobulin production (GO:0002639) | 3.69580676 |
| 45 | immune response-activating signal transduction (GO:0002757) | 3.68303462 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.67919478 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.67108060 |
| 48 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.64076632 |
| 49 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.61161662 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.60213475 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60213475 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.58282364 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57863844 |
| 54 | signal peptide processing (GO:0006465) | 3.55634091 |
| 55 | chronic inflammatory response (GO:0002544) | 3.52206329 |
| 56 | detection of bacterium (GO:0016045) | 3.51356734 |
| 57 | Fc receptor signaling pathway (GO:0038093) | 3.49894946 |
| 58 | detection of other organism (GO:0098543) | 3.47676353 |
| 59 | mature B cell differentiation involved in immune response (GO:0002313) | 3.41318205 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.40725842 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40677211 |
| 62 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.40209447 |
| 63 | eosinophil chemotaxis (GO:0048245) | 3.39904680 |
| 64 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.38228913 |
| 65 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.37432171 |
| 66 | negative T cell selection (GO:0043383) | 3.36392704 |
| 67 | B cell homeostasis (GO:0001782) | 3.34804279 |
| 68 | thymic T cell selection (GO:0045061) | 3.34684201 |
| 69 | angiotensin maturation (GO:0002003) | 3.31369325 |
| 70 | positive regulation of pseudopodium assembly (GO:0031274) | 3.29303097 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29136303 |
| 72 | activation of immune response (GO:0002253) | 3.28937050 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27307432 |
| 74 | B cell activation (GO:0042113) | 3.26415113 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 3.25947566 |
| 76 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25507939 |
| 77 | fucose catabolic process (GO:0019317) | 3.25068304 |
| 78 | L-fucose metabolic process (GO:0042354) | 3.25068304 |
| 79 | L-fucose catabolic process (GO:0042355) | 3.25068304 |
| 80 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.22007440 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20056104 |
| 82 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.19252113 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19133924 |
| 84 | negative regulation of myotube differentiation (GO:0010832) | 3.18905802 |
| 85 | regulation of integrin activation (GO:0033623) | 3.18228145 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17901230 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17827629 |
| 88 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.17755313 |
| 89 | positive regulation of B cell proliferation (GO:0030890) | 3.14480038 |
| 90 | positive regulation of B cell activation (GO:0050871) | 3.12217025 |
| 91 | type I interferon signaling pathway (GO:0060337) | 3.11232715 |
| 92 | cellular response to type I interferon (GO:0071357) | 3.11232715 |
| 93 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.11170695 |
| 94 | regulation of Rap GTPase activity (GO:0032317) | 3.10838574 |
| 95 | regulation of immunoglobulin production (GO:0002637) | 3.09723504 |
| 96 | dendritic cell chemotaxis (GO:0002407) | 3.08297095 |
| 97 | response to type I interferon (GO:0034340) | 3.07556677 |
| 98 | eosinophil migration (GO:0072677) | 3.05589898 |
| 99 | maternal placenta development (GO:0001893) | 3.03739727 |
| 100 | T cell selection (GO:0045058) | 3.03003021 |
| 101 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.01207739 |
| 102 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00762510 |
| 103 | response to interleukin-15 (GO:0070672) | 2.99412396 |
| 104 | germinal center formation (GO:0002467) | 2.96478652 |
| 105 | negative regulation of B cell apoptotic process (GO:0002903) | 2.95396570 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 2.94015812 |
| 107 | antimicrobial humoral response (GO:0019730) | 2.91877928 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91858122 |
| 109 | regulation of pseudopodium assembly (GO:0031272) | 2.90907235 |
| 110 | intestinal absorption (GO:0050892) | 2.90558800 |
| 111 | N-acetylneuraminate metabolic process (GO:0006054) | 2.90311569 |
| 112 | antibacterial humoral response (GO:0019731) | 2.89932445 |
| 113 | B cell mediated immunity (GO:0019724) | 2.89300870 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 2.86423228 |
| 115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86194613 |
| 116 | somatic diversification of immunoglobulins (GO:0016445) | 2.85714842 |
| 117 | defense response to protozoan (GO:0042832) | 2.85436654 |
| 118 | regulation of guanylate cyclase activity (GO:0031282) | 2.81646007 |
| 119 | lymphocyte homeostasis (GO:0002260) | 2.81210524 |
| 120 | negative regulation of gene silencing (GO:0060969) | 2.81128078 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80625631 |
| 122 | lymphocyte costimulation (GO:0031294) | 2.79613168 |
| 123 | regulation of interferon-alpha production (GO:0032647) | 2.78475431 |
| 124 | T cell costimulation (GO:0031295) | 2.78269943 |
| 125 | negative regulation of osteoclast differentiation (GO:0045671) | 2.78093077 |
| 126 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.78005618 |
| 127 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77774546 |
| 128 | B cell activation involved in immune response (GO:0002312) | 2.75306290 |
| 129 | bone resorption (GO:0045453) | 2.73576488 |
| 130 | myeloid dendritic cell differentiation (GO:0043011) | 2.73193163 |
| 131 | lymph node development (GO:0048535) | 2.73093859 |
| 132 | regulation of nuclease activity (GO:0032069) | 2.72526510 |
| 133 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.70050957 |
| 134 | GDP-mannose metabolic process (GO:0019673) | 2.69746614 |
| 135 | respiratory burst (GO:0045730) | 2.69512855 |
| 136 | cellular response to interferon-gamma (GO:0071346) | 2.69442934 |
| 137 | intestinal epithelial cell development (GO:0060576) | 2.68648415 |
| 138 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.68246344 |
| 139 | regulation of vitamin metabolic process (GO:0030656) | 2.67538415 |
| 140 | macrophage activation involved in immune response (GO:0002281) | 2.66348798 |
| 141 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.66279549 |
| 142 | positive regulation of response to oxidative stress (GO:1902884) | 2.66279549 |
| 143 | production of molecular mediator of immune response (GO:0002440) | 2.61593467 |
| 144 | myeloid dendritic cell activation (GO:0001773) | 2.58240375 |
| 145 | response to interferon-gamma (GO:0034341) | 2.57256209 |
| 146 | dendritic cell migration (GO:0036336) | 2.56651903 |
| 147 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56342365 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.55159639 |
| 149 | protein-chromophore linkage (GO:0018298) | 2.53874026 |
| 150 | virion attachment to host cell (GO:0019062) | 2.53717760 |
| 151 | adhesion of symbiont to host cell (GO:0044650) | 2.53717760 |
| 152 | T-helper 1 type immune response (GO:0042088) | 2.53408521 |
| 153 | regulation of necrotic cell death (GO:0010939) | 2.53360214 |
| 154 | arginine catabolic process (GO:0006527) | 2.51229334 |
| 155 | defense response to Gram-negative bacterium (GO:0050829) | 2.46486290 |
| 156 | epithelial structure maintenance (GO:0010669) | 2.45700453 |
| 157 | regulation of T cell tolerance induction (GO:0002664) | 2.44208890 |
| 158 | oligosaccharide biosynthetic process (GO:0009312) | 2.44117580 |
| 159 | peptide catabolic process (GO:0043171) | 2.42582854 |
| 160 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.40361599 |
| 161 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36161776 |
| 162 | morphogenesis of an endothelium (GO:0003159) | 2.35941129 |
| 163 | endothelial tube morphogenesis (GO:0061154) | 2.35941129 |
| 164 | regulation of protein heterodimerization activity (GO:0043497) | 2.35561420 |
| 165 | positive regulation of type 2 immune response (GO:0002830) | 2.32054985 |
| 166 | positive regulation of T cell migration (GO:2000406) | 2.30337415 |
| 167 | endocrine process (GO:0050886) | 2.30203018 |
| 168 | complement activation, classical pathway (GO:0006958) | 16.9081683 |
| 169 | complement activation (GO:0006956) | 12.8990666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.10024433 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.04760675 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.67701841 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.88802618 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.74490475 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.09676164 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.02954737 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.94779882 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.74413372 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.46637622 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32373975 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07690897 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.00860238 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.00478680 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85331579 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76523176 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.73168727 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.57562475 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.55769923 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.52564745 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.50948335 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39971501 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.38541073 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.25307828 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15767070 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15744647 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13668668 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12170075 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05370081 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03680073 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03450293 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97737969 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93097228 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93073704 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91768930 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.89571681 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.87544016 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.86605133 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84787950 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.83251932 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72191127 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69718065 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67521026 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67285470 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.61922391 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60161538 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58064877 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57493997 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56176460 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54329005 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54161349 |
| 52 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.51142758 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50386428 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46859738 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44554816 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44092852 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44009064 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42860093 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40358392 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40210517 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38960333 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37545502 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36592808 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33984069 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33508264 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.33366941 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32899027 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.31048581 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30079205 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29853950 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23637178 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22807373 |
| 73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21996955 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21935488 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21667267 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21278274 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20892393 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18649411 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16334142 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16132879 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13666885 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13060392 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12058086 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11961849 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10177330 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10014077 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09588108 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09391771 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08116073 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05340335 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04924189 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04785046 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04320229 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04253454 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01726932 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01194378 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01134645 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01074228 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99642728 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98258595 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97222352 |
| 102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97124125 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96887336 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96740758 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96675928 |
| 106 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96291398 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96251169 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95845355 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95583871 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94670651 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94669844 |
| 112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93641014 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92664368 |
| 114 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92313882 |
| 115 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92310476 |
| 116 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.91136803 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90165366 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89493952 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86145323 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85755304 |
| 121 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.85457287 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85148462 |
| 123 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83815747 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82783324 |
| 125 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82764790 |
| 126 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82719079 |
| 127 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81745350 |
| 128 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.81496609 |
| 129 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80237006 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80152233 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79280309 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78923869 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78483245 |
| 134 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78207729 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77481876 |
| 136 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77305382 |
| 137 | P300_27268052_Chip-Seq_Bcells_Human | 0.76994866 |
| 138 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.76987072 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76984866 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75653765 |
| 141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74591462 |
| 142 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74574242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.66119443 |
| 2 | MP0003303_peritoneal_inflammation | 5.57136812 |
| 3 | MP0001800_abnormal_humoral_immune | 5.00481363 |
| 4 | MP0001790_abnormal_immune_system | 4.33137796 |
| 5 | MP0005387_immune_system_phenotype | 4.33137796 |
| 6 | MP0003724_increased_susceptibility_to | 4.16990756 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.64899701 |
| 8 | MP0005671_abnormal_response_to | 3.55051757 |
| 9 | MP0002723_abnormal_immune_serum | 3.08247714 |
| 10 | MP0003300_gastrointestinal_ulcer | 3.04933976 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.96166168 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.93703090 |
| 13 | MP0000685_abnormal_immune_system | 2.88891112 |
| 14 | MP0001819_abnormal_immune_cell | 2.86684110 |
| 15 | MP0002398_abnormal_bone_marrow | 2.78785877 |
| 16 | MP0000716_abnormal_immune_system | 2.64675828 |
| 17 | MP0000689_abnormal_spleen_morphology | 2.38594575 |
| 18 | MP0001873_stomach_inflammation | 2.31412124 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.25203532 |
| 20 | MP0005166_decreased_susceptibility_to | 2.24274584 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.21501612 |
| 22 | MP0005025_abnormal_response_to | 2.20524391 |
| 23 | MP0002429_abnormal_blood_cell | 2.15786494 |
| 24 | MP0002722_abnormal_immune_system | 2.00217749 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.98914920 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.98851948 |
| 27 | MP0003436_decreased_susceptibility_to | 1.98231131 |
| 28 | MP0008004_abnormal_stomach_pH | 1.86039451 |
| 29 | MP0005310_abnormal_salivary_gland | 1.80945136 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.80436478 |
| 31 | MP0002419_abnormal_innate_immunity | 1.80028894 |
| 32 | MP0001853_heart_inflammation | 1.78158426 |
| 33 | MP0004947_skin_inflammation | 1.76617924 |
| 34 | MP0001879_abnormal_lymphatic_vessel | 1.76391928 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.76268061 |
| 36 | MP0002933_joint_inflammation | 1.75508951 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.75261817 |
| 38 | MP0004510_myositis | 1.72071683 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.69129457 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.64183348 |
| 41 | MP0002405_respiratory_system_inflammati | 1.62407900 |
| 42 | MP0006054_spinal_hemorrhage | 1.58960030 |
| 43 | MP0004858_abnormal_nervous_system | 1.55299476 |
| 44 | MP0009785_altered_susceptibility_to | 1.50926121 |
| 45 | MP0002006_tumorigenesis | 1.44101753 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.41448426 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.37829582 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.35772085 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.34934200 |
| 50 | MP0003866_abnormal_defecation | 1.32023821 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.30860212 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.26022652 |
| 53 | MP0002796_impaired_skin_barrier | 1.25278637 |
| 54 | MP0009840_abnormal_foam_cell | 1.22060554 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.20750985 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.15988907 |
| 57 | MP0006082_CNS_inflammation | 1.14421338 |
| 58 | MP0003448_altered_tumor_morphology | 1.13478827 |
| 59 | MP0000490_abnormal_crypts_of | 1.12939003 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.10949537 |
| 61 | MP0000604_amyloidosis | 1.10888844 |
| 62 | MP0001663_abnormal_digestive_system | 1.10107946 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.09074504 |
| 64 | MP0005409_darkened_coat_color | 1.06958540 |
| 65 | MP0009764_decreased_sensitivity_to | 1.05885949 |
| 66 | MP0001664_abnormal_digestion | 1.05731286 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.02817629 |
| 68 | MP0000343_altered_response_to | 1.01776778 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.01708711 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.00775409 |
| 71 | MP0003045_fibrosis | 1.00548866 |
| 72 | MP0005275_abnormal_skin_tensile | 0.99459617 |
| 73 | MP0008057_abnormal_DNA_replication | 0.97454975 |
| 74 | MP0001919_abnormal_reproductive_system | 0.96670029 |
| 75 | MP0003329_amyloid_beta_deposits | 0.94875195 |
| 76 | MP0009278_abnormal_bone_marrow | 0.94708279 |
| 77 | MP0000858_altered_metastatic_potential | 0.94497864 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.94291920 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.91398542 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.91358734 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.90955455 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.86428645 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.85912413 |
| 84 | MP0008469_abnormal_protein_level | 0.85257362 |
| 85 | MP0005390_skeleton_phenotype | 0.84756109 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.81034964 |
| 87 | MP0003279_aneurysm | 0.80335826 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.80023178 |
| 89 | MP0001533_abnormal_skeleton_physiology | 0.79247147 |
| 90 | MP0005451_abnormal_body_composition | 0.78634764 |
| 91 | MP0001851_eye_inflammation | 0.78128390 |
| 92 | MP0005365_abnormal_bile_salt | 0.76727987 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.76019138 |
| 94 | MP0008872_abnormal_physiological_respon | 0.75887935 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.73397925 |
| 96 | MP0003868_abnormal_feces_composition | 0.72004254 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.71089309 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68647365 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.68587452 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.67967923 |
| 101 | MP0005165_increased_susceptibility_to | 0.66777703 |
| 102 | MP0001191_abnormal_skin_condition | 0.66322163 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.66167968 |
| 104 | MP0005501_abnormal_skin_physiology | 0.65831306 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.65747311 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.65368375 |
| 107 | MP0003075_altered_response_to | 0.64887778 |
| 108 | MP0005023_abnormal_wound_healing | 0.64748543 |
| 109 | MP0000609_abnormal_liver_physiology | 0.63050809 |
| 110 | MP0002139_abnormal_hepatobiliary_system | 0.61894047 |
| 111 | MP0003077_abnormal_cell_cycle | 0.60501318 |
| 112 | MP0002083_premature_death | 0.60159154 |
| 113 | MP0005360_urolithiasis | 0.60017923 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.58102539 |
| 115 | MP0000733_abnormal_muscle_development | 0.57408326 |
| 116 | MP0008569_lethality_at_weaning | 0.56182567 |
| 117 | MP0002168_other_aberrant_phenotype | 0.56074708 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.55498474 |
| 119 | MP0008874_decreased_physiological_sensi | 0.53937247 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.53687067 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.52449610 |
| 122 | MP0008873_increased_physiological_sensi | 0.52367413 |
| 123 | MP0009763_increased_sensitivity_to | 0.51816718 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.50642540 |
| 125 | MP0003693_abnormal_embryo_hatching | 0.50108102 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.49531189 |
| 127 | MP0003091_abnormal_cell_migration | 0.47963335 |
| 128 | MP0005397_hematopoietic_system_phenotyp | 0.47649214 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.47649214 |
| 130 | MP0001730_embryonic_growth_arrest | 0.46146343 |
| 131 | MP0000920_abnormal_myelination | 0.45770392 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.44701596 |
| 133 | MP0002254_reproductive_system_inflammat | 0.44451676 |
| 134 | MP0000249_abnormal_blood_vessel | 0.43391560 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.42099281 |
| 136 | MP0003795_abnormal_bone_structure | 0.39804651 |
| 137 | MP0002169_no_abnormal_phenotype | 0.39683633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 7.28782041 |
| 2 | Abnormality of B cell number (HP:0010975) | 7.28782041 |
| 3 | Recurrent sinusitis (HP:0011108) | 7.15649807 |
| 4 | Colitis (HP:0002583) | 7.11149513 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.87979475 |
| 6 | Cellulitis (HP:0100658) | 6.61351303 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 6.49179861 |
| 8 | Verrucae (HP:0200043) | 5.97905572 |
| 9 | Papilloma (HP:0012740) | 5.97905572 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.85532449 |
| 11 | IgM deficiency (HP:0002850) | 5.55334521 |
| 12 | Prostate neoplasm (HP:0100787) | 5.54321056 |
| 13 | Inflammation of the large intestine (HP:0002037) | 5.54193392 |
| 14 | Recurrent viral infections (HP:0004429) | 5.48453858 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 5.36399814 |
| 16 | Meningitis (HP:0001287) | 5.32005683 |
| 17 | Abnormality of macrophages (HP:0004311) | 5.06062616 |
| 18 | Recurrent pneumonia (HP:0006532) | 4.76221592 |
| 19 | Malnutrition (HP:0004395) | 4.66062771 |
| 20 | Recurrent lower respiratory tract infections (HP:0002783) | 4.50232242 |
| 21 | Chronic sinusitis (HP:0011109) | 4.49214993 |
| 22 | Chronic otitis media (HP:0000389) | 4.33625333 |
| 23 | IgA deficiency (HP:0002720) | 4.21435558 |
| 24 | Emphysema (HP:0002097) | 4.12071238 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 4.04225599 |
| 26 | Osteomyelitis (HP:0002754) | 4.03451273 |
| 27 | Vasculitis (HP:0002633) | 4.00298410 |
| 28 | Bronchitis (HP:0012387) | 3.92759460 |
| 29 | Recurrent otitis media (HP:0000403) | 3.87604887 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.80451498 |
| 31 | Lymphopenia (HP:0001888) | 3.74646692 |
| 32 | IgG deficiency (HP:0004315) | 3.70383908 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.63385680 |
| 34 | Abnormality of complement system (HP:0005339) | 3.62672653 |
| 35 | Restrictive lung disease (HP:0002091) | 3.49765566 |
| 36 | Sepsis (HP:0100806) | 3.40835394 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 3.39157230 |
| 38 | Glomerulonephritis (HP:0000099) | 3.36487418 |
| 39 | Thyroiditis (HP:0100646) | 3.36337096 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.31644638 |
| 41 | Complement deficiency (HP:0004431) | 3.30739594 |
| 42 | Skin rash (HP:0000988) | 3.18887154 |
| 43 | Decreased circulating renin level (HP:0003351) | 3.13692744 |
| 44 | Recurrent fungal infections (HP:0002841) | 3.08594000 |
| 45 | Leukocytosis (HP:0001974) | 2.97400127 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95213781 |
| 47 | Small epiphyses (HP:0010585) | 2.88905923 |
| 48 | Abnormality of T cells (HP:0002843) | 2.86668339 |
| 49 | Chronic diarrhea (HP:0002028) | 2.86563149 |
| 50 | Abnormality of the peritoneum (HP:0002585) | 2.84797698 |
| 51 | Nephritis (HP:0000123) | 2.80272471 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.79540101 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.75573658 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.74540436 |
| 55 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.71082753 |
| 56 | Urticaria (HP:0001025) | 2.69254388 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.65406630 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.63209106 |
| 59 | Ankyloglossia (HP:0010296) | 2.61615697 |
| 60 | Metabolic alkalosis (HP:0200114) | 2.56709401 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.55937083 |
| 62 | Nasal polyposis (HP:0100582) | 2.50990657 |
| 63 | Alkalosis (HP:0001948) | 2.50600302 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.49870234 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48058304 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48058304 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.43508493 |
| 68 | Myositis (HP:0100614) | 2.42902517 |
| 69 | Abnormality of renin-angiotensin system (HP:0000847) | 2.40496477 |
| 70 | Gingivitis (HP:0000230) | 2.38781617 |
| 71 | Recurrent skin infections (HP:0001581) | 2.37352464 |
| 72 | Abnormality of male internal genitalia (HP:0000022) | 2.36240361 |
| 73 | Increased IgE level (HP:0003212) | 2.34884892 |
| 74 | Obstructive lung disease (HP:0006536) | 2.34864922 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34864922 |
| 76 | Skin ulcer (HP:0200042) | 2.33010632 |
| 77 | Viral hepatitis (HP:0006562) | 2.32088868 |
| 78 | T lymphocytopenia (HP:0005403) | 2.30532353 |
| 79 | Neoplasm of the lung (HP:0100526) | 2.30122853 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.28993536 |
| 81 | Optic neuritis (HP:0100653) | 2.28993536 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.27856693 |
| 83 | Mitral stenosis (HP:0001718) | 2.26703933 |
| 84 | Neutropenia (HP:0001875) | 2.23386992 |
| 85 | Encephalitis (HP:0002383) | 2.23311424 |
| 86 | Leukopenia (HP:0001882) | 2.21284315 |
| 87 | Lymphoma (HP:0002665) | 2.19458210 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.18566439 |
| 89 | Purpura (HP:0000979) | 2.10735955 |
| 90 | Increased IgM level (HP:0003496) | 2.10207017 |
| 91 | Abnormality of the pleura (HP:0002103) | 2.08646871 |
| 92 | Thrombocytosis (HP:0001894) | 2.07156517 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.07012289 |
| 94 | Bronchiectasis (HP:0002110) | 2.06299850 |
| 95 | Arthralgia (HP:0002829) | 2.05224287 |
| 96 | Hematochezia (HP:0002573) | 2.05062250 |
| 97 | Growth hormone excess (HP:0000845) | 2.04903762 |
| 98 | Combined immunodeficiency (HP:0005387) | 2.03579873 |
| 99 | Ileus (HP:0002595) | 2.02470406 |
| 100 | Agammaglobulinemia (HP:0004432) | 10.0212213 |
| 101 | Hypermelanotic macule (HP:0001034) | 1.98707975 |
| 102 | Neoplasm of the respiratory system (HP:0100606) | 1.97952842 |
| 103 | Hemorrhage of the eye (HP:0011885) | 1.95762498 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95494314 |
| 105 | Abnormality of the fingertips (HP:0001211) | 1.94898766 |
| 106 | Autoimmune hemolytic anemia (HP:0001890) | 1.94551519 |
| 107 | Polycythemia (HP:0001901) | 1.94042031 |
| 108 | Chest pain (HP:0100749) | 1.93702594 |
| 109 | Cerebral palsy (HP:0100021) | 1.92524581 |
| 110 | Flattened epiphyses (HP:0003071) | 1.91329328 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 1.90798309 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 1.90140125 |
| 113 | Petechiae (HP:0000967) | 1.88586540 |
| 114 | Pulmonary embolism (HP:0002204) | 1.87622604 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.86829639 |
| 116 | Orchitis (HP:0100796) | 1.86050862 |
| 117 | Abnormality of the prostate (HP:0008775) | 1.84971534 |
| 118 | Hemoptysis (HP:0002105) | 1.83007455 |
| 119 | Keratoconjunctivitis (HP:0001096) | 1.81805344 |
| 120 | Arterial thrombosis (HP:0004420) | 1.81335059 |
| 121 | Pustule (HP:0200039) | 1.69599122 |
| 122 | Basal cell carcinoma (HP:0002671) | 1.69467749 |
| 123 | Dehydration (HP:0001944) | 1.68989013 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68583894 |
| 125 | Eosinophilia (HP:0001880) | 1.60772024 |
| 126 | Limb hypertonia (HP:0002509) | 1.60407520 |
| 127 | Vertebral arch anomaly (HP:0008438) | 1.59847652 |
| 128 | Acrocyanosis (HP:0001063) | 1.58543068 |
| 129 | Ureteral stenosis (HP:0000071) | 1.56611949 |
| 130 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.56245514 |
| 131 | Abnormal foot bone ossification (HP:0010675) | 1.55047825 |
| 132 | Fatigue (HP:0012378) | 1.54205749 |
| 133 | Spontaneous hematomas (HP:0007420) | 1.53119799 |
| 134 | Papilledema (HP:0001085) | 1.49948284 |
| 135 | Hypergammaglobulinemia (HP:0010702) | 1.49314395 |
| 136 | Hepatitis (HP:0012115) | 1.48336357 |
| 137 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.48289895 |
| 138 | Villous atrophy (HP:0011473) | 1.48289895 |
| 139 | Irregular vertebral endplates (HP:0003301) | 1.46870366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.54278770 |
| 2 | ERN1 | 5.85557563 |
| 3 | PRPF4B | 3.13051536 |
| 4 | GRK6 | 2.99453378 |
| 5 | BLK | 2.96888898 |
| 6 | SYK | 2.95137955 |
| 7 | MST1R | 2.86622805 |
| 8 | MAP3K10 | 2.85216714 |
| 9 | RIPK4 | 2.73005948 |
| 10 | RIPK1 | 2.67870717 |
| 11 | CSF1R | 2.58501955 |
| 12 | TXK | 2.50204991 |
| 13 | TYK2 | 2.36714667 |
| 14 | TAOK3 | 2.33350856 |
| 15 | BTK | 2.10293931 |
| 16 | KIT | 2.05685181 |
| 17 | PRKCH | 2.04467148 |
| 18 | PIK3CA | 1.99072953 |
| 19 | SIK2 | 1.96771672 |
| 20 | MAP3K14 | 1.96052909 |
| 21 | SMG1 | 1.92645573 |
| 22 | TESK2 | 1.70965174 |
| 23 | JAK1 | 1.70764846 |
| 24 | EIF2AK3 | 1.69352492 |
| 25 | STK10 | 1.61755698 |
| 26 | LYN | 1.60244551 |
| 27 | MAP3K13 | 1.52529973 |
| 28 | EPHA3 | 1.50670895 |
| 29 | TBK1 | 1.49064349 |
| 30 | NME2 | 1.46654844 |
| 31 | LRRK2 | 1.46304871 |
| 32 | ACVR1B | 1.46214609 |
| 33 | ITK | 1.45045953 |
| 34 | PRKCQ | 1.31627449 |
| 35 | JAK3 | 1.29718724 |
| 36 | HCK | 1.25153007 |
| 37 | MAP3K1 | 1.24710479 |
| 38 | IRAK3 | 1.24292549 |
| 39 | TAOK1 | 1.23759203 |
| 40 | MST4 | 1.20829763 |
| 41 | ICK | 1.18554515 |
| 42 | IRAK4 | 1.18466489 |
| 43 | NEK2 | 1.10771575 |
| 44 | IKBKE | 1.09153363 |
| 45 | IKBKB | 1.09052525 |
| 46 | TESK1 | 1.08329448 |
| 47 | NLK | 1.07407413 |
| 48 | PRKG2 | 1.07314260 |
| 49 | HIPK2 | 1.04347645 |
| 50 | FGFR4 | 1.03111777 |
| 51 | EEF2K | 1.02557673 |
| 52 | LCK | 1.01859886 |
| 53 | CDK12 | 1.01536519 |
| 54 | TEC | 1.01313683 |
| 55 | EPHB2 | 1.00733193 |
| 56 | PRKCI | 0.98176247 |
| 57 | FGFR3 | 0.98175732 |
| 58 | MAP2K3 | 0.97567632 |
| 59 | EPHA2 | 0.96066775 |
| 60 | CLK1 | 0.95613233 |
| 61 | FES | 0.95382019 |
| 62 | TRIB3 | 0.91682270 |
| 63 | ALK | 0.87275418 |
| 64 | STK24 | 0.87090470 |
| 65 | STK39 | 0.84904197 |
| 66 | PIM1 | 0.83748673 |
| 67 | MAP3K11 | 0.80111168 |
| 68 | CSK | 0.78961625 |
| 69 | PIK3CG | 0.77074554 |
| 70 | MAP3K9 | 0.74506308 |
| 71 | MET | 0.73930890 |
| 72 | NEK9 | 0.72906324 |
| 73 | MAP3K3 | 0.72496409 |
| 74 | TGFBR2 | 0.71673905 |
| 75 | LMTK2 | 0.68193953 |
| 76 | IRAK1 | 0.68158835 |
| 77 | SIK1 | 0.66647034 |
| 78 | YES1 | 0.66100093 |
| 79 | MAP2K2 | 0.63969579 |
| 80 | ZAP70 | 0.63664376 |
| 81 | PDPK1 | 0.63267820 |
| 82 | DDR2 | 0.63209160 |
| 83 | TAOK2 | 0.62917185 |
| 84 | MAP3K6 | 0.62868846 |
| 85 | MARK3 | 0.62398250 |
| 86 | JAK2 | 0.62320850 |
| 87 | BUB1 | 0.60539477 |
| 88 | PDK1 | 0.59479807 |
| 89 | FYN | 0.56548413 |
| 90 | RET | 0.56121234 |
| 91 | PDGFRA | 0.55518426 |
| 92 | MAPK7 | 0.54167917 |
| 93 | FER | 0.54150458 |
| 94 | PRKD1 | 0.53440242 |
| 95 | GRK5 | 0.50616715 |
| 96 | OXSR1 | 0.50132115 |
| 97 | BMX | 0.48927532 |
| 98 | DMPK | 0.48925364 |
| 99 | CHUK | 0.47541679 |
| 100 | CDK4 | 0.47009561 |
| 101 | PRKD2 | 0.46713776 |
| 102 | PRKCD | 0.46429581 |
| 103 | EPHB1 | 0.45810100 |
| 104 | CDC42BPA | 0.45171567 |
| 105 | CSNK1A1L | 0.44169353 |
| 106 | ABL1 | 0.42746945 |
| 107 | BRD4 | 0.42318829 |
| 108 | MAPK12 | 0.42119875 |
| 109 | PKN2 | 0.42033407 |
| 110 | MATK | 0.41394431 |
| 111 | TNK2 | 0.41084087 |
| 112 | MAP3K7 | 0.39679792 |
| 113 | MAPK11 | 0.38381004 |
| 114 | MAP3K2 | 0.37799985 |
| 115 | CSNK1G3 | 0.37349981 |
| 116 | SIK3 | 0.37004431 |
| 117 | KDR | 0.36707865 |
| 118 | INSR | 0.36695253 |
| 119 | RPS6KA4 | 0.35824338 |
| 120 | MAPK4 | 0.34893764 |
| 121 | RPS6KL1 | 0.34314278 |
| 122 | RPS6KC1 | 0.34314278 |
| 123 | FRK | 0.34015803 |
| 124 | BCKDK | 0.33382219 |
| 125 | MAP3K5 | 0.30914464 |
| 126 | CSNK1G1 | 0.29777578 |
| 127 | CDK6 | 0.27277089 |
| 128 | CCNB1 | 0.26731580 |
| 129 | MAPK3 | 0.26091501 |
| 130 | CDC7 | 0.26067418 |
| 131 | TGFBR1 | 0.25440339 |
| 132 | EGFR | 0.25149057 |
| 133 | KSR2 | 0.24986545 |
| 134 | MAP3K8 | 0.24436073 |
| 135 | CSNK1G2 | 0.23868624 |
| 136 | MELK | 0.23150360 |
| 137 | CDK9 | 0.22928310 |
| 138 | MAPKAPK2 | 0.21604307 |
| 139 | PKN1 | 0.21019343 |
| 140 | FGR | 0.19917271 |
| 141 | BMPR2 | 0.19779950 |
| 142 | PTK6 | 0.19356170 |
| 143 | SGK3 | 0.18787926 |
| 144 | GRK1 | 0.18225295 |
| 145 | BRSK1 | 0.17757878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.50262202 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.59842652 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.01825235 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.87131439 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.83914638 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.66881394 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.29595004 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24749424 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.17305190 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.04605622 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01331757 |
| 12 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.97365773 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.94323980 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93461310 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91840648 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90032532 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81972185 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80169209 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.76482543 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.72703334 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66954529 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59713201 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58526811 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40308902 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38691832 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38222578 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.35074303 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.22946824 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.18372319 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17651696 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13748413 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13180009 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.11098590 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.10500428 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09228295 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07626289 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.05431817 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97053592 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96417425 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96013574 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93673638 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 0.93194264 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92171904 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90069909 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89369389 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.89222113 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88005130 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87732579 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87360528 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84948942 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84854013 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84656238 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.83645053 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83287068 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82537151 |
| 56 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82443811 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82126176 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.80142532 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.78295563 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76826851 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76713169 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76318771 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73909646 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72076740 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70919637 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70756048 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70644058 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69996889 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68207995 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.66383292 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65143333 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61906011 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61158278 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.60451531 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.59846101 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59125956 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58479474 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58077567 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57289722 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57036080 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.53809195 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53602099 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52734597 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52346648 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.51957504 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51881762 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50692509 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49790953 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49042606 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48861310 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48802151 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48652125 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47587833 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47574057 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45883192 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44294006 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43753466 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.43657345 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43228341 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.42874678 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42761265 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42030138 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41828732 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41769304 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41531735 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41418364 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39702969 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38967773 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37504115 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.37465393 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36969548 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35858187 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35703772 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.34433463 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34201401 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33352435 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.31962603 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.31002065 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29778880 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27108332 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26933627 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25938499 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.25083952 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.22699051 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22266724 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21584490 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20194018 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20171940 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.19358018 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19292160 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17228406 |
| 132 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15885011 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.13261738 |
| 134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.13094705 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12981447 |
| 136 | Spliceosome_Homo sapiens_hsa03040 | 0.11800650 |
| 137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.11586159 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11527199 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10945433 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.10111763 |
| 141 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09869269 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.09589751 |

